Oncology Billing for Washington healthcare providers.
Washington is the largest oncology billing market in District of Columbia. The NPPES registry lists 34 oncology billing organizations at a Washington practice location, which is 100.0 percent of the 34 oncology billing organizations registered across District of Columbia. That places Washington at number 1 of 1 District of Columbia oncology billing markets the registry tracks, making it a dominant hub that anchors the state's claim volume. At about 1.0 times the average District of Columbia market size of 34 organizations, Washington sits in the compact state table.
The Washington oncology billing market.
As the leading oncology billing market in District of Columbia, Washington sets the pace for statewide payer behavior. Its 34 organizations carry enough claim volume to support specialized oncology billing sub-markets across every major District of Columbia payer, and authorization rules established here tend to become the de facto statewide norm. The District of Columbia cities below operate at a fraction of Washington's density.
Provider landscape: Washington vs nearby District of Columbia cities.
Washington accounts for 100.0 percent of District of Columbia's oncology billing organizations. It holds the top spot in the state by registered organization count. The table compares Washington against its nearest District of Columbia neighbors so you can see where local volume sits relative to the state leader, Washington.
| District of Columbia city | NPPES oncology billing orgs | Share of state |
|---|---|---|
| Washington | 34 | 100.0% |
Washington ranks in the compact state table of District of Columbia's 1 tracked oncology billing markets at 100.0 percent of the state total. Counts are NPPES-registered oncology billing organizations at a practice location in each District of Columbia city. For statewide payer and Medicaid detail, see the District of Columbia oncology billing overview.
Payer environment in Washington.
Washington oncology billing providers contract with the same District of Columbia payer set: DC Medicaid, the dominant District of Columbia Blue Cross Blue Shield plan, the national commercials (UnitedHealthcare/Optum, Aetna, Cigna), and Tricare East (where applicable). Each carries its own prior authorization workflow and medical necessity criteria, so the Washington payer mix drives the local denial profile. With Washington holding 100.0 percent of the state's oncology billing organizations as a dominant market, at Washington's scale, a billing team must handle the full breadth of plan-specific authorization rules at high volume, since payer relationships established here tend to set statewide norms.
District of Columbia Medicaid and Washington routing.
DC Medicaid covers oncology billing for eligible District of Columbia beneficiaries, delivering most of that benefit through managed care organizations with a remaining fee-for-service population. The most common District of Columbia Medicaid denials seen in Washington are prior authorization missing or expired, plan-of-record mismatch (patient assigned to different MCO), medical necessity documentation insufficient, timely filing exceeded, and managed care vs FFS routing errors. Because each MCO credentials providers separately and enrollment runs 60-120 days from clean application, confirming plan assignment and credentialing status before the first Washington visit is decisive for clean first-pass payment. Across Washington's 34 organizations, even a few percentage points of MCO-routing error compounds into material rework.
What is hard about oncology billing revenue cycle in Washington.
For the largest oncology billing provider base in District of Columbia, all 34 organizations of it, the operational pressure points are consistent: missing or expired prior authorizations, plan-of-record mismatches when a patient is assigned to a different MCO, insufficient medical necessity documentation, timely-filing lapses, and managed-care versus fee-for-service routing errors. Because Washington carries 100.0 percent of District of Columbia's oncology billing organizations and ranks 1 of 1 in the state, its denial exposure scales with that footprint. In Washington these are where oncology billing margin is won or lost, so clean documentation, accurate plan assignment, and tight authorization tracking pay back fastest for the city's 34 oncology billing organizations.
Where Washington providers win.
In Washington the practical edge is operational. Systematize the District of Columbia Medicaid MCO versus fee-for-service split, hold each MCO credentialing file to the 60-120 days from clean application enrollment window, and track realization by payer. With 34 Washington oncology billing organizations, about 1.0 times the average District of Columbia market, competing for the same District of Columbia payer dollars in the compact state table, the providers that run a disciplined revenue cycle capture share fastest while competitors at this dominant tier lose it to denials and underpayments.
FAQ: oncology billing in Washington.
How many oncology billing providers operate in Washington, District of Columbia?
NPPES lists 34 oncology billing organizations at a Washington practice location, which is 100.0 percent of all District of Columbia oncology billing organizations. That ranks Washington number 1 of 1 District of Columbia oncology billing markets, against a statewide total of 34.
Does DC Medicaid cover oncology billing for Washington providers?
Yes. DC Medicaid covers oncology billing for eligible District of Columbia beneficiaries in Washington through managed care organizations and a fee-for-service population. Enrollment runs 60-120 days from clean application, and each MCO credentials providers separately.
Which commercial payers cover oncology billing in Washington?
The Washington commercial landscape is led by DC Medicaid, the dominant District of Columbia Blue Cross Blue Shield plan, the national commercials (UnitedHealthcare/Optum, Aetna, Cigna), and Tricare East (where applicable). Tricare East applies to eligible military families. Each plan carries its own authorization workflow.
What drives oncology billing denials in Washington?
The most common District of Columbia oncology billing denials in Washington are prior authorization missing or expired, plan-of-record mismatch (patient assigned to different MCO), medical necessity documentation insufficient, timely filing exceeded, and managed care vs FFS routing errors. Mapping these to the local Washington payer mix is the fastest way to lift first-pass yield.
Does ASP-RCM serve oncology billing providers in Washington?
Yes. ASP-RCM Solutions provides oncology billing billing and credentialing for providers in Washington and across District of Columbia, with senior partners on every account.
Primary source: